FDA Approved: TEMODAR — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved a supplemental application for Temodar (temozolomide) from Merck, resulting in an updated labeling and/or indication for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma
• Malignant Glioma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

SUPPL AP for TEMODAR (TEMOZOLOMIDE)